| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alveolar Epithelial Cells | 5 | 2021 | 28 | 2.490 |
Why?
|
| Pulmonary Surfactants | 16 | 2021 | 41 | 1.720 |
Why?
|
| Energy Metabolism | 3 | 2021 | 222 | 1.600 |
Why?
|
| Lactic Acid | 2 | 2021 | 86 | 1.280 |
Why?
|
| Milk, Human | 6 | 2022 | 147 | 1.110 |
Why?
|
| Lung | 10 | 2021 | 849 | 1.070 |
Why?
|
| Cryopreservation | 2 | 2014 | 103 | 0.850 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2021 | 11 | 0.830 |
Why?
|
| Proteolipids | 14 | 1999 | 20 | 0.820 |
Why?
|
| Steroids | 1 | 2021 | 84 | 0.780 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2021 | 66 | 0.770 |
Why?
|
| Oxygen | 2 | 2021 | 386 | 0.750 |
Why?
|
| Pulmonary Alveoli | 4 | 2015 | 62 | 0.740 |
Why?
|
| Epithelial Cells | 4 | 2015 | 431 | 0.660 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2021 | 626 | 0.660 |
Why?
|
| Vitamin D | 8 | 2022 | 516 | 0.650 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 6 | 2013 | 11 | 0.630 |
Why?
|
| Hemoglobins | 2 | 2010 | 120 | 0.620 |
Why?
|
| Macrophages, Alveolar | 3 | 2010 | 34 | 0.620 |
Why?
|
| Oxygen Consumption | 2 | 2015 | 258 | 0.590 |
Why?
|
| Cell Line | 8 | 2021 | 1752 | 0.530 |
Why?
|
| Glucose | 1 | 2015 | 307 | 0.450 |
Why?
|
| Mice | 19 | 2021 | 8472 | 0.450 |
Why?
|
| Membrane Lipids | 3 | 2003 | 31 | 0.440 |
Why?
|
| Mitochondria | 3 | 2015 | 643 | 0.440 |
Why?
|
| Lipid Bilayers | 3 | 2003 | 24 | 0.440 |
Why?
|
| Breast Feeding | 4 | 2022 | 159 | 0.430 |
Why?
|
| Animals | 37 | 2021 | 20877 | 0.430 |
Why?
|
| Proteomics | 4 | 2021 | 246 | 0.400 |
Why?
|
| Whales | 1 | 2011 | 6 | 0.400 |
Why?
|
| Respiratory Mucosa | 3 | 2007 | 52 | 0.400 |
Why?
|
| Primary Cell Culture | 1 | 2011 | 56 | 0.390 |
Why?
|
| Inflammation | 3 | 2019 | 1030 | 0.390 |
Why?
|
| Rhinitis, Allergic, Perennial | 3 | 2007 | 43 | 0.390 |
Why?
|
| Oxocins | 1 | 2010 | 2 | 0.380 |
Why?
|
| Dietary Supplements | 3 | 2022 | 331 | 0.350 |
Why?
|
| Gene Expression Regulation | 5 | 2017 | 1293 | 0.350 |
Why?
|
| Hypoxia | 1 | 2010 | 169 | 0.340 |
Why?
|
| Cell Hypoxia | 3 | 2015 | 92 | 0.340 |
Why?
|
| Vitamin D-Binding Protein | 2 | 2019 | 58 | 0.340 |
Why?
|
| Up-Regulation | 2 | 2010 | 682 | 0.330 |
Why?
|
| Immunity, Innate | 2 | 2013 | 156 | 0.320 |
Why?
|
| Fungal Proteins | 1 | 2007 | 37 | 0.310 |
Why?
|
| Obesity | 4 | 2019 | 1074 | 0.310 |
Why?
|
| Cystic Fibrosis | 3 | 2007 | 283 | 0.300 |
Why?
|
| Humans | 38 | 2022 | 68525 | 0.290 |
Why?
|
| Models, Biological | 3 | 2021 | 981 | 0.280 |
Why?
|
| Cytokines | 5 | 2021 | 866 | 0.280 |
Why?
|
| Spectrophotometry, Infrared | 2 | 2003 | 25 | 0.270 |
Why?
|
| Gene Expression | 4 | 2010 | 770 | 0.260 |
Why?
|
| Surface-Active Agents | 3 | 2019 | 57 | 0.250 |
Why?
|
| RNA, Messenger | 6 | 2021 | 1663 | 0.250 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 3 | 2011 | 8 | 0.250 |
Why?
|
| Glycolysis | 2 | 2015 | 79 | 0.250 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 5 | 2007 | 16 | 0.240 |
Why?
|
| Dioctyl Sulfosuccinic Acid | 3 | 2019 | 15 | 0.240 |
Why?
|
| Phospholipids | 5 | 2008 | 108 | 0.240 |
Why?
|
| Lactation | 3 | 2022 | 110 | 0.240 |
Why?
|
| Pregnancy Trimesters | 2 | 2021 | 14 | 0.240 |
Why?
|
| Lipids | 2 | 2004 | 298 | 0.240 |
Why?
|
| Pregnancy | 9 | 2022 | 2331 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 2790 | 0.230 |
Why?
|
| Infant Nutritional Physiological Phenomena | 2 | 2022 | 72 | 0.230 |
Why?
|
| Phosphatidylethanolamines | 2 | 2001 | 20 | 0.230 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 3 | 2007 | 15 | 0.230 |
Why?
|
| Amyloid | 1 | 2003 | 39 | 0.230 |
Why?
|
| Infant, Premature | 2 | 2022 | 284 | 0.220 |
Why?
|
| Infant | 7 | 2022 | 2891 | 0.220 |
Why?
|
| Cholecalciferol | 2 | 2020 | 143 | 0.220 |
Why?
|
| Cattle | 12 | 2012 | 475 | 0.220 |
Why?
|
| Mothers | 2 | 2022 | 172 | 0.210 |
Why?
|
| Lactalbumin | 1 | 2021 | 2 | 0.210 |
Why?
|
| Cytotoxins | 1 | 2021 | 23 | 0.210 |
Why?
|
| Terbutaline | 1 | 2021 | 23 | 0.210 |
Why?
|
| Oleic Acids | 1 | 2021 | 40 | 0.210 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2021 | 67 | 0.210 |
Why?
|
| A549 Cells | 1 | 2021 | 50 | 0.210 |
Why?
|
| Betamethasone | 1 | 2021 | 24 | 0.210 |
Why?
|
| Body Fluids | 1 | 2021 | 41 | 0.210 |
Why?
|
| Food Handling | 1 | 2021 | 34 | 0.210 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2021 | 54 | 0.210 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2020 | 146 | 0.200 |
Why?
|
| Sheep | 1 | 2021 | 128 | 0.200 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2013 | 12 | 0.200 |
Why?
|
| Bone Density | 1 | 2022 | 159 | 0.200 |
Why?
|
| Fibroblasts | 5 | 2021 | 902 | 0.200 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 434 | 0.190 |
Why?
|
| Dexamethasone | 1 | 2021 | 150 | 0.190 |
Why?
|
| Case-Control Studies | 3 | 2021 | 1548 | 0.190 |
Why?
|
| Transfection | 4 | 2005 | 782 | 0.190 |
Why?
|
| Female | 19 | 2022 | 38015 | 0.190 |
Why?
|
| Bottle Feeding | 1 | 2020 | 20 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 219 | 0.190 |
Why?
|
| Isoenzymes | 1 | 2021 | 308 | 0.190 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 121 | 0.190 |
Why?
|
| Bottle-Nosed Dolphin | 2 | 2014 | 86 | 0.180 |
Why?
|
| Glucocorticoids | 1 | 2021 | 222 | 0.180 |
Why?
|
| Pre-Eclampsia | 2 | 2012 | 202 | 0.180 |
Why?
|
| Vitamin D Deficiency | 1 | 2022 | 292 | 0.170 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 498 | 0.170 |
Why?
|
| Petroleum | 2 | 2016 | 14 | 0.170 |
Why?
|
| Nutrition Policy | 1 | 2019 | 44 | 0.170 |
Why?
|
| Respiratory Syncytial Viruses | 3 | 2013 | 9 | 0.170 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 37 | 0.160 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 6 | 2003 | 9 | 0.160 |
Why?
|
| Endothelial Cells | 2 | 2012 | 384 | 0.160 |
Why?
|
| Adiposity | 1 | 2019 | 88 | 0.160 |
Why?
|
| PPAR gamma | 2 | 2016 | 95 | 0.160 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2017 | 5 | 0.160 |
Why?
|
| Therapeutics | 1 | 2017 | 7 | 0.160 |
Why?
|
| Dyslipidemias | 1 | 2019 | 98 | 0.160 |
Why?
|
| Hormones | 1 | 2017 | 42 | 0.160 |
Why?
|
| Polylysine | 2 | 1995 | 13 | 0.160 |
Why?
|
| Infant, Newborn | 5 | 2022 | 2453 | 0.150 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 154 | 0.150 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2017 | 42 | 0.150 |
Why?
|
| Scleroderma, Systemic | 1 | 2021 | 446 | 0.150 |
Why?
|
| Microscopy, Fluorescence | 2 | 2012 | 261 | 0.150 |
Why?
|
| Cell Culture Techniques | 2 | 2009 | 189 | 0.140 |
Why?
|
| Myofibroblasts | 1 | 2017 | 60 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2017 | 147 | 0.140 |
Why?
|
| Hexoses | 1 | 2016 | 5 | 0.140 |
Why?
|
| Emulsifying Agents | 1 | 2016 | 5 | 0.140 |
Why?
|
| Petroleum Pollution | 1 | 2016 | 6 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2017 | 126 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 627 | 0.140 |
Why?
|
| Hyaluronan Receptors | 1 | 2017 | 142 | 0.140 |
Why?
|
| Food | 1 | 2016 | 52 | 0.140 |
Why?
|
| Leigh Disease | 1 | 2015 | 3 | 0.140 |
Why?
|
| Electron Transport Complex I | 1 | 2015 | 20 | 0.140 |
Why?
|
| Succinates | 1 | 2015 | 9 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 247 | 0.140 |
Why?
|
| Pulmonary Fibrosis | 1 | 2017 | 157 | 0.130 |
Why?
|
| Environmental Pollutants | 2 | 2014 | 180 | 0.130 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2015 | 15 | 0.130 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 226 | 0.130 |
Why?
|
| Symporters | 1 | 2015 | 27 | 0.130 |
Why?
|
| Paranasal Sinuses | 2 | 2007 | 165 | 0.130 |
Why?
|
| Cell Respiration | 1 | 2015 | 47 | 0.130 |
Why?
|
| Pneumonia | 2 | 2013 | 110 | 0.130 |
Why?
|
| Tissue Banks | 1 | 2014 | 13 | 0.130 |
Why?
|
| Microarray Analysis | 1 | 2014 | 63 | 0.130 |
Why?
|
| Liposomes | 3 | 2004 | 107 | 0.120 |
Why?
|
| Proton Ionophores | 1 | 2014 | 7 | 0.120 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2014 | 14 | 0.120 |
Why?
|
| DNA, Recombinant | 1 | 1994 | 25 | 0.120 |
Why?
|
| Adult | 7 | 2021 | 21375 | 0.120 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 62 | 0.120 |
Why?
|
| Glycogen | 1 | 2014 | 27 | 0.120 |
Why?
|
| Cryoprotective Agents | 1 | 2014 | 31 | 0.120 |
Why?
|
| Protein Stability | 1 | 2014 | 89 | 0.120 |
Why?
|
| RNA Stability | 1 | 2014 | 55 | 0.120 |
Why?
|
| Carbon | 1 | 2015 | 122 | 0.120 |
Why?
|
| Cells, Cultured | 5 | 2013 | 2673 | 0.120 |
Why?
|
| Endotoxins | 1 | 2013 | 76 | 0.120 |
Why?
|
| Drug Carriers | 1 | 1994 | 90 | 0.120 |
Why?
|
| Molecular Weight | 2 | 2004 | 358 | 0.120 |
Why?
|
| Homeostasis | 2 | 2014 | 291 | 0.110 |
Why?
|
| Lung Diseases | 2 | 2008 | 175 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2014 | 189 | 0.110 |
Why?
|
| Leukocytes | 2 | 2022 | 99 | 0.110 |
Why?
|
| Lung Injury | 1 | 2013 | 38 | 0.110 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2012 | 13 | 0.110 |
Why?
|
| Pregnancy Proteins | 1 | 2012 | 15 | 0.110 |
Why?
|
| Adipocytes | 2 | 2016 | 88 | 0.110 |
Why?
|
| Cytological Techniques | 1 | 2012 | 23 | 0.110 |
Why?
|
| Environmental Exposure | 1 | 2014 | 269 | 0.110 |
Why?
|
| Protein Conformation | 3 | 2003 | 362 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 5 | 2008 | 852 | 0.100 |
Why?
|
| Fetal Blood | 1 | 2012 | 131 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2012 | 1173 | 0.100 |
Why?
|
| Cell Survival | 1 | 2014 | 901 | 0.100 |
Why?
|
| Phosphatidylglycerols | 4 | 2003 | 8 | 0.100 |
Why?
|
| Procollagen | 1 | 2011 | 31 | 0.100 |
Why?
|
| Culture Media | 1 | 2011 | 155 | 0.100 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2011 | 44 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2011 | 144 | 0.100 |
Why?
|
| Mucous Membrane | 2 | 2007 | 66 | 0.100 |
Why?
|
| Marine Toxins | 1 | 2010 | 14 | 0.100 |
Why?
|
| Fetal Development | 1 | 2011 | 70 | 0.100 |
Why?
|
| Erythroid Cells | 1 | 2010 | 5 | 0.100 |
Why?
|
| GATA1 Transcription Factor | 1 | 2010 | 19 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2015 | 284 | 0.090 |
Why?
|
| Peptides | 1 | 2013 | 455 | 0.090 |
Why?
|
| Heme | 1 | 2010 | 17 | 0.090 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2010 | 17 | 0.090 |
Why?
|
| Phagocytosis | 1 | 2010 | 65 | 0.090 |
Why?
|
| Protein Structure, Secondary | 3 | 2003 | 136 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 1174 | 0.090 |
Why?
|
| Nasal Mucosa | 2 | 2007 | 68 | 0.090 |
Why?
|
| Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2009 | 3 | 0.090 |
Why?
|
| DNA, Single-Stranded | 1 | 2009 | 41 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2014 | 718 | 0.090 |
Why?
|
| Microvilli | 1 | 2009 | 22 | 0.090 |
Why?
|
| Telomere | 1 | 2009 | 59 | 0.090 |
Why?
|
| Air | 1 | 2009 | 22 | 0.090 |
Why?
|
| Tight Junctions | 1 | 2009 | 25 | 0.090 |
Why?
|
| Polyurethanes | 1 | 2009 | 21 | 0.090 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2008 | 21 | 0.090 |
Why?
|
| Penaeidae | 1 | 2008 | 16 | 0.080 |
Why?
|
| Blotting, Western | 3 | 2008 | 954 | 0.080 |
Why?
|
| Enzyme Inhibitors | 2 | 2010 | 659 | 0.080 |
Why?
|
| Dependovirus | 1 | 2008 | 34 | 0.080 |
Why?
|
| Neoplasm Proteins | 2 | 2008 | 307 | 0.080 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2008 | 15 | 0.080 |
Why?
|
| Androgens | 1 | 2008 | 40 | 0.080 |
Why?
|
| Surface Properties | 4 | 1996 | 363 | 0.080 |
Why?
|
| Organoselenium Compounds | 1 | 2008 | 17 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 1082 | 0.080 |
Why?
|
| Succinic Acid | 1 | 2007 | 9 | 0.080 |
Why?
|
| Chemokine CCL11 | 1 | 2007 | 9 | 0.080 |
Why?
|
| Fluorescence Polarization | 3 | 1992 | 14 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 1446 | 0.080 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2008 | 133 | 0.080 |
Why?
|
| Immune System | 1 | 2007 | 63 | 0.080 |
Why?
|
| Models, Animal | 1 | 2008 | 252 | 0.080 |
Why?
|
| Sulfhydryl Compounds | 1 | 2007 | 73 | 0.080 |
Why?
|
| Th1 Cells | 1 | 2007 | 101 | 0.070 |
Why?
|
| Double-Blind Method | 2 | 2022 | 1737 | 0.070 |
Why?
|
| Osteitis Deformans | 1 | 2006 | 19 | 0.070 |
Why?
|
| Kininogens | 1 | 2006 | 88 | 0.070 |
Why?
|
| Globins | 1 | 2006 | 13 | 0.070 |
Why?
|
| Fluorescent Dyes | 3 | 1992 | 191 | 0.070 |
Why?
|
| 3T3-L1 Cells | 2 | 2016 | 30 | 0.070 |
Why?
|
| Acylation | 2 | 2003 | 22 | 0.070 |
Why?
|
| Ethers | 1 | 2005 | 13 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 1990 | 617 | 0.070 |
Why?
|
| Multigene Family | 1 | 2006 | 93 | 0.070 |
Why?
|
| Sulfones | 1 | 2005 | 45 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2007 | 241 | 0.070 |
Why?
|
| Biomarkers | 3 | 2021 | 1593 | 0.060 |
Why?
|
| Child | 3 | 2022 | 6400 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2020 | 1745 | 0.060 |
Why?
|
| Milk Proteins | 1 | 2004 | 22 | 0.060 |
Why?
|
| Biological Availability | 1 | 2004 | 79 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2016 | 326 | 0.060 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 122 | 0.060 |
Why?
|
| Mice, 129 Strain | 2 | 2013 | 44 | 0.060 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2015 | 139 | 0.060 |
Why?
|
| Solutions | 1 | 2003 | 115 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2003 | 618 | 0.060 |
Why?
|
| Endocytosis | 2 | 2001 | 113 | 0.060 |
Why?
|
| Biological Products | 2 | 2013 | 78 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2003 | 246 | 0.060 |
Why?
|
| Adipogenesis | 2 | 2016 | 17 | 0.060 |
Why?
|
| Citric Acid Cycle | 2 | 2015 | 15 | 0.050 |
Why?
|
| Infant Formula | 1 | 2022 | 24 | 0.050 |
Why?
|
| Fumarates | 2 | 2015 | 28 | 0.050 |
Why?
|
| Food Storage | 1 | 2021 | 7 | 0.050 |
Why?
|
| Caseins | 1 | 2021 | 19 | 0.050 |
Why?
|
| Goblet Cells | 2 | 2013 | 9 | 0.050 |
Why?
|
| Cysteine | 2 | 2015 | 112 | 0.050 |
Why?
|
| Orbital Diseases | 1 | 2002 | 21 | 0.050 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2002 | 40 | 0.050 |
Why?
|
| Kinetics | 3 | 2012 | 1047 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2022 | 75 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 778 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 1032 | 0.050 |
Why?
|
| Eye | 1 | 2002 | 89 | 0.050 |
Why?
|
| Vitamins | 1 | 2022 | 134 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2015 | 2550 | 0.050 |
Why?
|
| Mass Spectrometry | 2 | 2015 | 284 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2001 | 71 | 0.050 |
Why?
|
| Luciferases | 1 | 2001 | 105 | 0.050 |
Why?
|
| Plant Extracts | 1 | 2022 | 122 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2001 | 147 | 0.050 |
Why?
|
| Feeding Methods | 1 | 2020 | 17 | 0.050 |
Why?
|
| Bacteria | 1 | 2022 | 193 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 492 | 0.050 |
Why?
|
| Male | 8 | 2019 | 37281 | 0.050 |
Why?
|
| Rats | 3 | 2006 | 5300 | 0.050 |
Why?
|
| DNA | 2 | 2001 | 597 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2020 | 67 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2015 | 1692 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2001 | 173 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2001 | 311 | 0.050 |
Why?
|
| Sunlight | 1 | 2020 | 59 | 0.050 |
Why?
|
| Macrophages | 1 | 2004 | 647 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2001 | 241 | 0.050 |
Why?
|
| Immune Tolerance | 1 | 2020 | 114 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2001 | 330 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2019 | 36 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2009 | 117 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2007 | 1085 | 0.040 |
Why?
|
| Infant Nutrition Disorders | 1 | 2017 | 6 | 0.040 |
Why?
|
| Diet | 1 | 2021 | 513 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 3 | 1995 | 4 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1034 | 0.040 |
Why?
|
| Hyaluronan Synthases | 1 | 2017 | 21 | 0.040 |
Why?
|
| Glucuronosyltransferase | 1 | 2017 | 38 | 0.040 |
Why?
|
| Adenoviridae | 2 | 1995 | 295 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 1999 | 382 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 1999 | 455 | 0.040 |
Why?
|
| Oleic Acid | 1 | 2016 | 40 | 0.040 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2016 | 18 | 0.040 |
Why?
|
| Young Adult | 3 | 2012 | 5708 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2017 | 206 | 0.030 |
Why?
|
| Brain Stem | 1 | 2015 | 46 | 0.030 |
Why?
|
| Time Factors | 3 | 2013 | 4655 | 0.030 |
Why?
|
| Biopsy | 2 | 2007 | 539 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 710 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 120 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 2 | 1993 | 112 | 0.030 |
Why?
|
| Adsorption | 3 | 2005 | 225 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2021 | 824 | 0.030 |
Why?
|
| Gulf of Mexico | 1 | 2014 | 5 | 0.030 |
Why?
|
| Atlantic Ocean | 1 | 2014 | 22 | 0.030 |
Why?
|
| Aroclors | 1 | 2014 | 22 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 1993 | 765 | 0.030 |
Why?
|
| Geography | 1 | 2014 | 80 | 0.030 |
Why?
|
| Defective Viruses | 1 | 1994 | 2 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1994 | 26 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-gamma | 1 | 2013 | 1 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 209 | 0.030 |
Why?
|
| Bronchi | 1 | 1994 | 59 | 0.030 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2013 | 23 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 3702 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2013 | 89 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2013 | 79 | 0.030 |
Why?
|
| 3T3 Cells | 2 | 2007 | 124 | 0.030 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2014 | 147 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2013 | 114 | 0.030 |
Why?
|
| Fourier Analysis | 1 | 1992 | 31 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 1992 | 25 | 0.030 |
Why?
|
| Biophysics | 1 | 1992 | 41 | 0.030 |
Why?
|
| Placenta Growth Factor | 1 | 2012 | 12 | 0.030 |
Why?
|
| Dolphins | 1 | 2012 | 11 | 0.030 |
Why?
|
| Viral Load | 1 | 2013 | 127 | 0.030 |
Why?
|
| Cell Size | 1 | 2012 | 76 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2007 | 1329 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2012 | 59 | 0.030 |
Why?
|
| Membranes, Artificial | 1 | 1992 | 88 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2012 | 57 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2012 | 242 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2012 | 122 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 244 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2012 | 238 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2019 | 3185 | 0.030 |
Why?
|
| Benzhydryl Compounds | 1 | 2012 | 62 | 0.030 |
Why?
|
| Phenols | 1 | 2012 | 73 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1992 | 420 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1992 | 397 | 0.030 |
Why?
|
| ROC Curve | 1 | 2012 | 392 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2013 | 447 | 0.020 |
Why?
|
| Apoproteins | 1 | 1991 | 11 | 0.020 |
Why?
|
| Thermodynamics | 2 | 2005 | 162 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1265 | 0.020 |
Why?
|
| Temperature | 1 | 1992 | 340 | 0.020 |
Why?
|
| Employment | 1 | 2012 | 154 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1991 | 94 | 0.020 |
Why?
|
| Protein Binding | 2 | 2009 | 1027 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 880 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 1989 | 38 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 60 | 0.020 |
Why?
|
| Collectins | 1 | 2009 | 2 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 137 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2009 | 83 | 0.020 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2009 | 13 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1046 | 0.020 |
Why?
|
| RNA, Double-Stranded | 1 | 2009 | 13 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2009 | 38 | 0.020 |
Why?
|
| Fusarium | 1 | 2008 | 5 | 0.020 |
Why?
|
| Phenotype | 1 | 2012 | 946 | 0.020 |
Why?
|
| Vibrio | 1 | 2008 | 14 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2009 | 89 | 0.020 |
Why?
|
| Leishmania donovani | 1 | 1988 | 19 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2009 | 112 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 248 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1419 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2008 | 149 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2009 | 231 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2009 | 179 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2008 | 196 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 50 | 0.020 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2008 | 61 | 0.020 |
Why?
|
| Tritium | 1 | 2008 | 101 | 0.020 |
Why?
|
| Ligands | 1 | 2009 | 317 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 631 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2008 | 33 | 0.020 |
Why?
|
| RNA Interference | 1 | 2008 | 266 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2008 | 411 | 0.020 |
Why?
|
| Lysine | 1 | 2007 | 96 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2007 | 251 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2007 | 254 | 0.020 |
Why?
|
| Mycoses | 1 | 2007 | 60 | 0.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2006 | 10 | 0.020 |
Why?
|
| Etoposide | 1 | 2006 | 64 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 320 | 0.020 |
Why?
|
| Antibodies | 1 | 2007 | 241 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2006 | 69 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2007 | 221 | 0.020 |
Why?
|
| Spectral Karyotyping | 1 | 2005 | 4 | 0.020 |
Why?
|
| Keratins | 1 | 2005 | 48 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2006 | 81 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2007 | 215 | 0.020 |
Why?
|
| Surface Tension | 1 | 2005 | 13 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2005 | 100 | 0.020 |
Why?
|
| Phospholipases A | 1 | 2005 | 41 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2007 | 249 | 0.020 |
Why?
|
| Epidermis | 1 | 2005 | 42 | 0.020 |
Why?
|
| Weight Loss | 1 | 2008 | 319 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2006 | 217 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 175 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2005 | 85 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 2264 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1851 | 0.020 |
Why?
|
| Nasal Polyps | 1 | 2007 | 184 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 1849 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 2005 | 180 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 2688 | 0.020 |
Why?
|
| Epithelium | 2 | 1997 | 172 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 756 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 1199 | 0.010 |
Why?
|
| Microscopy, Electron | 2 | 1995 | 351 | 0.010 |
Why?
|
| Rhinitis | 1 | 2007 | 383 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 1070 | 0.010 |
Why?
|
| Sinusitis | 1 | 2007 | 432 | 0.010 |
Why?
|
| Heterozygote | 1 | 1999 | 174 | 0.010 |
Why?
|
| Apoptosis | 1 | 2006 | 1640 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 8903 | 0.010 |
Why?
|
| Spermine | 1 | 1999 | 49 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 1999 | 201 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 1999 | 163 | 0.010 |
Why?
|
| Dinitrophenols | 1 | 1997 | 4 | 0.010 |
Why?
|
| Risk Factors | 1 | 2007 | 5719 | 0.010 |
Why?
|
| Oscillometry | 1 | 1996 | 5 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 1996 | 43 | 0.010 |
Why?
|
| Pressure | 1 | 1996 | 252 | 0.010 |
Why?
|
| Mutation | 1 | 1999 | 1213 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1997 | 475 | 0.010 |
Why?
|
| Energy Transfer | 1 | 1993 | 25 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 2083 | 0.010 |
Why?
|
| Fibrinogen | 1 | 1991 | 87 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1991 | 104 | 0.010 |
Why?
|
| Cricetinae | 1 | 1989 | 262 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1989 | 532 | 0.010 |
Why?
|
| Dimethadione | 1 | 1988 | 1 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1988 | 49 | 0.010 |
Why?
|
| Mathematics | 1 | 1988 | 83 | 0.010 |
Why?
|
| Phosphates | 1 | 1988 | 72 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1997 | 1172 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1989 | 523 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1989 | 483 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1988 | 346 | 0.000 |
Why?
|